A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
01/2014
01/30/2014	US20140030523 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
01/30/2014	US20140030316 Transdermal administration of fentanyl and analogs thereof
01/29/2014	CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
01/28/2014	US8637497 AZA spiro alkane derivatives as inhibitors of metalloproteases
01/28/2014	US8637073 Treatment of dependence withdrawal
01/23/2014	US20140024719 Antiseptic compositions, methods and systems
01/23/2014	US20140023731 Composition for treating aids and associated conditions
01/23/2014	US20140023598 Functional fragrance precursor
01/22/2014	CN1852687B Method for the preparation of controlled release formulations
01/21/2014	US8632962 PLKS as modifiers of the beta catenin pathway and methods of use
01/21/2014	CA2555149C Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
01/14/2014	US8629123 Use of dextran sulfate
01/14/2014	US8628797 Oral extended-release composition
01/14/2014	CA2550929C Antiseptic compositions, methods and systems
01/14/2014	CA2548771C A medical solution, a method for producing said medical solution and use thereof
01/14/2014	CA2526690C Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
01/14/2014	CA2373375C Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
01/07/2014	US8623835 Materials and methods for treatment of respiratory allergic diseases
01/07/2014	US8623412 Abuse-resistant pharmaceutical compositions
01/07/2014	US8623408 Cladribine formulations for improved oral and transmucosal delivery
01/07/2014	US8623365 Aβ binding molecules
01/07/2014	US8623323 Thickened beverages for dysphagia
01/01/2014	CN101264093B Compositions for increasing energy in vivo
12/2013
12/31/2013	CA2536699C Anti-virus hydrophilic polymeric material
12/31/2013	CA2534298C Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
12/31/2013	CA2523001C Therapeutic use of anti-cs1 antibodies
12/26/2013	US20130345410 Novel antibacterial agents
12/26/2013	US20130345236 Pharmaceutical compositions providing enhanced drug concentrations
12/26/2013	US20130344046 Methods For The Dietary Management Of Irritable Bowel Syndrome And Carbohydrate Malabsorption
12/25/2013	CN101787073B Methods and compositions for treatment of gastrointestinal disorders
12/24/2013	US8614313 Pharmaceutical compositions comprising forms of 5-azacytidine
12/24/2013	US8614064 Methods of diagnosing atherosclerosis by measuring ApoCI
12/24/2013	US8613917 Combination bacteriolytic therapy for the treatment of tumors
12/24/2013	CA2529307C Methods and compositions for the treatment of gastrointestinal disorders
12/24/2013	CA2500822C Nodulisporic acid derivative spot-on formulations for combating parasites
12/19/2013	US20130338148 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
12/19/2013	US20130338076 Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
12/19/2013	US20130338063 Methods and Compositions for the Treatment of Gastrointestinal Disorders
12/18/2013	EP2177626B1 Screening methods for cognitive enhancers
12/18/2013	EP1663110B1 Uses of interferons with altered spatial structure
12/18/2013	EP1648427B1 Low dose IgM antibody treatment of demyelinating disorders
12/18/2013	EP1613272B1 Method for preparation of site-specific protein conjugates
12/17/2013	US8609830 Methods and compositions for RNA interference
12/17/2013	US8609109 HIV vaccine formulations
12/17/2013	US8609104 Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates
12/17/2013	CA2492598C Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
12/11/2013	EP2671581A2 Compositions and methods for treating cancer
12/10/2013	CA2544235C Dialysates and methods and systems related thereto
12/10/2013	CA2498108C A composition for treating aids and associated conditions
12/03/2013	US8598316 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
12/03/2013	US8598192 Hydroxylamine substituted imidazoquinolines
12/03/2013	US8598180 Tetrahydroindolone derivatives for treatment of neurological conditions
12/03/2013	US8598133 Methods for treating pain
12/03/2013	US8597653 Asymmetrically branched polymer conjugates and microarray assays
12/03/2013	CA2499837C Human papillomavirus polypeptides and immunogenic compositions
11/2013
11/28/2013	US20130315863 Methods and compositions for treating flaviviridae infections
11/26/2013	US8592361 Functional fragrance precursor
11/26/2013	US8591917 Ganglioside based vaccine compositions for subcutaneous administration
11/26/2013	US8591904 Asymmetrically branched polymer conjugates and microarray assays
11/26/2013	US8591894 Humanized antibodies that sequester amyloid beta peptide
11/26/2013	CA2549103C Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
11/26/2013	CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/21/2013	US20130310336 Methods and compositions for treating flaviviruses and pestiviruses
11/21/2013	US20130309240 Compositions and Methods including a Recombinant Human MAB that Promotes CNS Remyelination
11/21/2013	US20130306069 Low Dose Pharmaceutical Powders for Inhalation
11/20/2013	EP2664331A1 Novel Antibacterial Agents
11/20/2013	EP1694347B1 Glycopegylated erythropoietin
11/20/2013	CN1832956B Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/19/2013	US8586076 Compositions comprising dietary fat complexer and methods for their use
11/19/2013	CA2532802C Antibiotic compound isolated from streptomyces sp
11/19/2013	CA2515929C Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
11/14/2013	US20130304086 ROBOTIC ARMS DLUs FOR PERFORMING SURGICAL TASKS
11/13/2013	EP2662087A1 Somatostatin vectors
11/12/2013	US8580796 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/12/2013	CA2673334C Oral extended-release composition
11/12/2013	CA2537093C Compound capable of binding s1p receptor and pharmaceutical use thereof
11/07/2013	US20130296359 Treatment of solid tumors with rapamycin derivatives
11/07/2013	US20130295159 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
11/05/2013	US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013	US8575137 Composition for inhalation
11/05/2013	CA2529103C Use of a recombinant vector encoding il-10 for treating neuropathic pain
11/05/2013	CA2512673C 2-o sulfatase compositions and related methods
10/2013
10/31/2013	US20130287839 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
10/31/2013	US20130287769 Treatment of solid tumors with rapamycin derivatives
10/30/2013	EP2657248A1 AAV virions with decreased immunoreactivity and uses therefor
10/30/2013	EP2657247A1 AAV virions with decreased immunoreactivity and uses therefor
10/30/2013	CN1922199B CA6 antigen-specific cytotoxic conjugate and methods of using same
10/29/2013	US8568748 Pharmaceutical formulation comprising cyclosporin and use thereof
10/29/2013	CA2549409C Glycopegylated granulocyte colony stimulating factor
10/22/2013	US8563255 Monoclonal antibody capable of binding integrin alpha 10 beta 1
10/22/2013	US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/22/2013	US8562992 Immunoglobulin variants and uses thereof
10/22/2013	CA2538146C Pyridomorphinans, pyridazinomorphinans and use thereof
10/17/2013	US20130273534 Socs-3 promoter methylation in cancer
10/17/2013	US20130273009 Methods to mobilize progenitor/stem cells
10/15/2013	US8557512 Method of screening activators and/or inhibitors of insulin receptor substrate 2
10/15/2013	US8557240 Method for the treatment of inflammatory disorders
10/15/2013	CA2494844C Methods and compositions concerning poxviruses and cancer
10/10/2013	US20130266600 Functional Mutations In Respiratory Syncytial Virus
10/10/2013	US20130263388 Epilatory Compositions

1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 295